TD Cowen analyst Gary Taylor lowered the firm’s price target on UnitedHealth to $546 from $607 and keeps a Buy rating on the shares. The firm sees 2024 EPS pressure building from an array of reasons, most notably the higher 2023 exit-rate of Medicare Advantage costs for both UnitedHealth and Optum.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on UNH:
- UnitedHealth price target lowered to $534 from $551 at Barclays
- UnitedHealth price target lowered to $584 from $618 at Morgan Stanley
- UnitedHealth Group (NYSE:UNH) Slides despite Analyst Upgrade
- UnitedHealth price target lowered to $570 from $600 at Argus
- HSBC upgrades UnitedHealth to Hold with risks priced in
